Vitamin C (CAS 50-81-7): Atomic Evidence for Anticancer Use

Executive Summary: Vitamin C (ascorbic acid) is a water-soluble vitamin (C6H8O6, MW 176.12) with high purity (≥98%) and validated anticancer and apoptosis-inducing effects in multiple preclinical models (product_spec). At 100–200 μg/mL, it inhibits tumor cell proliferation, while at 200–1000 μg/mL, it induces apoptosis in murine colon cancer cells (workflow_recommendation). In vivo, Vitamin C reduces tumor volumes in CT26 and 4T1 mouse models (workflow_recommendation). Vitamin C is highly soluble in water (≥57.9 mg/mL) and should be stored at –20°C for optimal stability (product_spec). These features make APExBIO’s B2064 formulation suitable for advanced cancer and organoid-based antiviral research (workflow_recommendation).

Biological Rationale

Vitamin C is an essential micronutrient for humans, acting as a potent antioxidant and enzyme cofactor. Its deficiency impairs collagen synthesis, immune response, and redox homeostasis. Ascorbic acid’s biomedical interest extends to its observed anticancer and antiviral properties. These effects are attributed to its ability to modulate cellular proliferation, apoptosis, and resistance to oxidative stress (DOI:10.1136/gutjnl-2025-336105). The use of high-purity, water-soluble Vitamin C formulations, such as APExBIO’s B2064, enables reproducible experimental outcomes, especially in the context of translational cancer and organoid virology research.

Mechanism of Action of Vitamin C (CAS 50-81-7)

Vitamin C exerts its anticancer activity through several mechanisms. In murine colon cancer (CT26) cells, it inhibits proliferation at concentrations of 100–200 μg/mL and induces apoptosis at 200–1000 μg/mL, demonstrating dose-dependent cytotoxicity (workflow_recommendation). Mechanistically, Vitamin C modulates redox balance, leading to increased reactive oxygen species (ROS) that trigger apoptosis pathways. It also affects gene expression involved in cell cycle control and apoptosis, including upregulation of pro-apoptotic proteins. In vivo, Vitamin C administration results in significant tumor volume reduction in both CT26 and 4T1 mouse models, supporting its relevance as an adjunct in cancer research (workflow_recommendation).

Evidence & Benchmarks

• Vitamin C inhibits CT26 murine colon cancer cell proliferation at 100–200 μg/mL in vitro (source: workflow_recommendation).
• Apoptosis induction is observed at 200–1000 μg/mL in the same model (source: workflow_recommendation).
• In vivo, Vitamin C reduces tumor volume in CT26 and 4T1 tumor-bearing BALB/c mice (source: workflow_recommendation).
• Solubility: ≥57.9 mg/mL in water, ≥12.2 mg/mL in ethanol (ultrasonic assistance), ≥5.8 mg/mL in DMSO (source: product_spec).
• Product is ≥98% purity, supplied as a solid, with HPLC and NMR quality control (source: product_spec).
• Vitamin C demonstrates efficacy in advanced organoid models for antiviral research by modulating cellular redox states (source: workflow_recommendation).
• iPSC-derived organoids provide physiologically relevant models for antiviral drug testing, including Vitamin C’s actions (source: DOI:10.1136/gutjnl-2025-336105).

Compared to the article "Vitamin C (CAS 50-81-7): Atomic Evidence for Anticancer a...", this dossier provides protocol-driven benchmarks and cross-model context, emphasizing product-grade purity and workflow integration steps. The article "Vitamin C (CAS 50-81-7): Advanced Protocols for Anticance..." is extended here by explicit numeric solubility and storage parameters. Additionally, "Vitamin C (CAS 50-81-7): Mechanistic Frontiers in Cancer ..." is clarified with direct evidence from in vivo and organoid models.

Applications, Limits & Misconceptions

Vitamin C is widely used in cancer research as an apoptosis inducer and antiproliferative agent. In organoid and animal models, it offers a validated platform for exploring tumor cell proliferation inhibition and redox-based antiviral strategies. However, its in vitro efficacy does not always predict clinical outcomes due to differences in pharmacokinetics and tumor microenvironment. The use of high-purity formulations, such as APExBIO’s B2064, ensures experimental reproducibility and reliability across advanced research applications.

Common Pitfalls or Misconceptions

• Oral Vitamin C supplementation does not replicate the plasma concentrations achieved by direct in vitro addition or parenteral administration (source: workflow_recommendation).
• Vitamin C is not uniformly effective across all cancer types; sensitivity varies by tumor genotype and microenvironment (source: workflow_recommendation).
• Antiviral efficacy in organoid models does not guarantee clinical benefit in patients (source: DOI:10.1136/gutjnl-2025-336105).
• Long-term storage of Vitamin C solutions leads to rapid degradation and loss of potency (source: product_spec).
• Using low-purity or improperly stored Vitamin C can result in irreproducible or misleading results (source: workflow_recommendation).

Workflow Integration & Parameters

Protocol Parameters

• in vitro proliferation assay | 100–200 μg/mL | CT26 murine colon cancer cells | Benchmarked for dose-dependent antiproliferative effect | workflow_recommendation
• apoptosis induction assay | 200–1000 μg/mL | CT26 cells | Validated for robust apoptosis induction | workflow_recommendation
• in vivo tumor reduction | 4 g/kg (i.p., q.d.) | BALB/c mice (CT26/4T1) | Protocol used for tumor volume reduction studies | workflow_recommendation
• solubility test | ≥57.9 mg/mL in water | All research applications | Enables preparation of concentrated stock solutions | product_spec
• storage conditions | –20°C (solid) | All formats | Maintains compound purity and stability | product_spec
• solution storage | immediate use after preparation | All solution-based assays | Prevents degradation and loss of activity | workflow_recommendation

Conclusion & Outlook

Vitamin C (CAS 50-81-7), as supplied by APExBIO, is a rigorously validated, high-purity apoptosis inducer and anticancer agent for translational research. Its atomic, dose-dependent effects on tumor cell proliferation and apoptosis are reproducible in both in vitro and in vivo models. The compound’s solubility profile and validated protocol parameters facilitate advanced cancer and organoid-based antiviral research workflows. Ongoing studies in iPSC-derived organoids will further define its role in antiviral drug evaluation and host-pathogen interaction research, as highlighted by recent HEV organoid model advancements (DOI:10.1136/gutjnl-2025-336105).